Karyotypically abnormal human ESCs are sensitive to HDAC inhibitors and show altered regulation of genes linked to cancers and neurological diseases

Stem Cell Research

Volumn 11, Issue 3, 2013, Pages 1022-1036

  Lund, Riikka J ^a,b   Emani, Maheswara Reddy ^b   Barbaric, Ivana ^a   Kivinen, Virpi ^c   Jones, Mark ^a   Baker, Duncan ^a   Gokhale, Paul ^a   Nykter, Matti ^b,c   Lahesmaa, Riitta ^b   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; M CARBOXYCINNAMIC ACID BIS HYDROXAMIDE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; GENETIC LINKAGE; GENETIC REGULATION; GENOMIC INSTABILITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; KARYOTYPING; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RETINOBLASTOMA;

EID: 84882258176     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.07.002     Document Type: Article

References (47)

1. Amano H., Itakura K., Maruyama M., Ichisaka T., Nakagawa M., Yamanaka S. Identification and targeted disruption of the mouse gene encoding ESG1 (PH34/ECAT2/DPPA5). BMC Dev. Biol. 2006, 6:11. 10.1186/1471-213X-6-11.
2. Andrews P.W. The selfish stem cell. Nat. Biotechnol. 2006, 24(3):325-326. (doi:nbt0306-325). 10.1038/nbt0306-325.
3. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 2007, 25(2):207-215. (doi:nbt1285 [pii]). 10.1038/nbt1285.
4. Barbaric I., Gokhale P.J., Andrews P.W. High-content screening of small compounds on human embryonic stem cells. Biochem. Soc. Trans. 2010, 38(4):1046-1050. 10.1042/BST0381046.
5. Barbaric I., Jones M., Harley D.J., Gokhale P.J., Andrews P.W. High-content screening for chemical modulators of embryonal carcinoma cell differentiation and survival. J. Biomol. Screen. 2011, 16(6):603-617. 10.1177/1087057111406547.
6. Ben-David U., Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 2011, 11(4):268-277. 10.1038/nrc3034.
7. Brehm A., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998, 391(6667):597-601. 10.1038/35404.
8. Brunmeir R., Lagger S., Seiser C. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int. J. Dev. Biol. 2009, 53(2-3):275-289. 10.1387/ijdb.082649rb.
9. Chateauvieux S., Morceau F., Dicato M., Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. J. Biomed. Biotechnol. 2010, 479364. (Epub 2010 Jul 29). 10.1155/2010/479364.
10. Coffey D.C., Kutko M.C., Glick R.D., Butler L.M., Heller G., Rifkind R.A., La Quaglia M.P. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. Cancer Res. 2001, 61(9):3591-3594.
11. Cunliffe V.T., Casaccia-Bonnefil P. Histone deacetylase 1 is essential for oligodendrocyte specification in the zebrafish CNS. Mech. Dev. 2006, 123(1):24-30. 10.1016/j.mod.2005.10.005.
12. Dokmanovic M., Clarke C., Marks P.A. Histone deacetylase inhibitors: overview and perspectives. Mol. Cancer Res. 2007, 5(10):981-989. 10.1158/1541-7786.MCR-07-0324.
13. Dovey O.M., Foster C.T., Cowley S.M. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(18):8242-8247. 10.1073/pnas.1000478107.
14. Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., Andrews P.W. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 2004, 22:53-54. (Epub 2003 Dec 7).
15. Enver T., Soneji S., Joshi C., Brown J., Iborra F., Orntoft T., Andrews P.W. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum. Mol. Genet. 2005, 14(21):3129-3140. (doi:ddi345 [pii]). 10.1093/hmg/ddi345.
16. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., Sleeman J.P., Lo Coco F., Nervi C., Giuseppe Pelicci P., Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001, 20(24):6969-6978. 10.1093/emboj/20.24.6969.
17. Herszfeld D., Wolvetang E., Langton-Bunker E., Chung T.L., Filipczyk A.A., Houssami S., Pera M.F. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat. Biotechnol. 2006, 24(3):351-357. 10.1038/nbt1197.
18. Humphrey G.W., Wang Y.H., Hirai T., Padmanabhan R., Panchision D.M., Newell L.F., Howard B.H. Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells. Differentiation 2008, 76(4):348-356. 10.1111/j.1432-0436.2007.00232.x.
19. International Stem Cell Initiative, Amps K., Andrews P.W., Anyfantis G., Armstrong L., Avery S., Zhou Q. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 2011, 29(12):1132-1144. 10.1038/nbt.2051.
20. Kaji K., Caballero I.M., MacLeod R., Nichols J., Wilson V.A., Hendrich B. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nat. Cell Biol. 2006, 8(3):285-292. 10.1038/ncb1372.
21. Kaji K., Nichols J., Hendrich B. Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells. Development 2007, 134(6):1123-1132. 10.1242/dev.02802.
22. Kelly W.K., Marks P.A. Drug insight: histone deacetylase inhibitors-development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat. Clin. Pract. Oncol. 2005, 2(3):150-157. 10.1038/ncponc0106.
23. Kidder B.L., Palmer S. HDAC1 regulates pluripotency and lineage specific transcriptional networks in embryonic and trophoblast stem cells. Nucleic Acids Res. 2012, 40(7):2925-2939. 10.1093/nar/gkr1151.
24. Kramer O.H., Zhu P., Ostendorff H.P., Golebiewski M., Tiefenbach J., Peters M.A., Brill B., Groner B., Bach I., Heinzel T., Gottlicher M. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 2003, 22(13):3411-3420. 10.1093/emboj/cdg315.
25. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002, 21(11):2672-2681. 10.1093/emboj/21.11.2672.
26. Lahdesmaki H., Rust A.G., Shmulevich I. Probabilistic inference of transcription factor binding from multiple data sources. PLoS One 2008, 3(3):e1820. 10.1371/journal.pone.0001820.
27. Laurent L.C., Ulitsky I., Slavin I., Tran H., Schork A., Morey R., Loring J.F. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8(1):106-118. 10.1016/j.stem.2010.12.003.
28. Liang J., Wan M., Zhang Y., Gu P., Xin H., Jung S.Y., Songyang Z. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 2008, 10(6):731-739. 10.1038/ncb1736.
29. Lund R.J., Ylikoski E.K., Aittokallio T., Nevalainen O., Lahesmaa R. Kinetics and STAT4- or STAT6-mediated regulation of genes involved in lymphocyte polarization to Th1 and Th2 cells. Eur. J. Immunol. 2003, 33(4):1105-1116. 10.1002/eji.200323899.
30. Lund R.J., Narva E., Lahesmaa R. Genetic and epigenetic stability of human pluripotent stem cells. Nat. Rev. Genet 2012, 10.1038/nrg3271.
31. Luo R.X., Postigo A.A., Dean D.C. Rb interacts with histone deacetylase to repress transcription. Cell 1998, 92(4):463-473.
32. Luo J., Su F., Chen D., Shiloh A., Gu W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 2000, 408(6810):377-381. 10.1038/35042612.
33. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J.P., Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998, 391(6667):601-605. 10.1038/35410.
34. Maitra A., Arking D.E., Shivapurkar N., Ikeda M., Stastny V., Kassauei K., Chakravarti A. Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 2005, 37(10):1099-1103. 10.1038/ng1631.
35. Miller K.M., Tjeertes J.V., Coates J., Legube G., Polo S.E., Britton S., Jackson S.P. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat. Struct. Mol. Biol. 2010, 17(9):1144-1151. 10.1038/nsmb.1899.
36. Narva E., Rahkonen N., Emani M.R., Lund R., Pursiheimo J.P., Nasti J., Lahesmaa R. RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation. Stem Cells 2012, 30(3):452-460. 10.1002/stem.1013.
37. Pazolli E., Alspach E., Milczarek A., Prior J., Piwnica-Worms D., Stewart S.A. Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer Res. 2012, 72(9):2251-2261. 10.1158/0008-5472.CAN-11-3386.
38. Pegoraro G., Kubben N., Wickert U., Gohler H., Hoffmann K., Misteli T. Ageing-related chromatin defects through loss of the NURD complex. Nat. Cell Biol. 2009, 11(10):1261-1267. 10.1038/ncb1971.
39. Reynolds N., Latos P., Hynes-Allen A., Loos R., Leaford D., O'Shaughnessy A., Hendrich B. NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment. Cell Stem Cell 2012, 10(5):583-594. 10.1016/j.stem.2012.02.020.
40. Taapken S.M., Nisler B.S., Newton M.A., Sampsell-Barron T.L., Leonhard K.A., McIntire E.M., Montgomery K.D. Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat. Biotechnol. 2011, 29(4):313-314. 10.1038/nbt.1835.
41. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
42. Wada T., Kikuchi J., Nishimura N., Shimizu R., Kitamura T., Furukawa Y. Expression levels of histone deacetylases determine the cell fate of hematopoietic progenitors. J. Biol. Chem. 2009, 284(44):30673-30683. 10.1074/jbc.M109.042242.
43. Ware C.B., Wang L., Mecham B.H., Shen L., Nelson A.M., Bar M., Blau C.A. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell 2009, 4(4):359-369. 10.1016/j.stem.2009.03.001.
44. Werbowetski-Ogilvie T.E., Bosse M., Stewart M., Schnerch A., Ramos-Mejia V., Rouleau A., Bhatia M. Characterization of human embryonic stem cells with features of neoplastic progression. Nat. Biotechnol. 2009, 27(1):91-97. 10.1038/nbt.1516.
45. Willis-Martinez D., Richards H.W., Timchenko N.A., Medrano E.E. Role of HDAC1 in senescence, aging, and cancer. Exp. Gerontol. 2010, 45(4):279-285. 10.1016/j.exger.2009.10.001.
46. Zafarana G., Avery S.R., Avery K., Moore H.D., Andrews P.W. Specific knockdown of OCT4 in human embryonic stem cells by inducible short hairpin RNA interference. Stem Cells 2009, 27(4):776-782. 10.1002/stem.5.
47. Zupkovitz G., Tischler J., Posch M., Sadzak I., Ramsauer K., Egger G., Seiser C. Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell. Biol. 2006, 26(21):7913-7928. 10.1128/MCB.01220-06.